BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37868325)

  • 21. Chronic Diarrhea Secondary to Newly Diagnosed VIPoma.
    Farina DA; Krogh KM; Boike JR
    Case Rep Gastroenterol; 2019; 13(1):225-229. PubMed ID: 31123451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life-threating diarrhea and acute renal failure secondary to pancreatic VIPoma treated by surgery.
    Lapeña Rodríguez M; Cholvi Calduch R; Muñoz Forner E; Garcés Albir M; Sabater Ortí L
    Rev Esp Enferm Dig; 2019 Aug; 111(8):641-643. PubMed ID: 31232078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report.
    Thivacaren S; Suganthan N; Sujanitha V; Sutharshan V
    Cureus; 2022 Mar; 14(3):e22819. PubMed ID: 35273891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
    Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
    Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
    Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
    J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.
    Belei O; Basaca DG; Heredea ER; Iacob ER; Olariu L; Folescu R; Motoc AGM; Nanu AM; Mărginean O
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Verner-Morrison syndrome: a case study].
    Halászlaki C; Horváth H; Kiss L; Takács I; Speer G; Nagy Z; Winternitz T; Dabasi G; Zalatnai A; Patócs A; Lakatos P
    Orv Hetil; 2010 Jul; 151(27):1111-4. PubMed ID: 20558361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
    Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
    Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic VIPomas from China: Case reports and literature review.
    Chen C; Zheng Z; Li B; Zhou L; Pang J; Wu W; Zheng C; Zhao Y
    Pancreatology; 2019 Jan; 19(1):44-49. PubMed ID: 30391116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental 68Ga-DOTATATE uptake in the pancreatic head: A case report and a unique opportunity to improve clinical care.
    Lakhotia R; Jhawar S; Malayeri AA; Millo C; Del Rivero J; Ahlman MA
    Medicine (Baltimore); 2020 May; 99(22):e20197. PubMed ID: 32481385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma.
    Krainev AA; Mathavan VK; Klink DF; Saxe JM; Ong GKB; Murphy JK
    J Surg Case Rep; 2019 Jun; 2019(6):rjz196. PubMed ID: 31275551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute renal failure caused by VIP-secreting tumor].
    Lambertini D; Bottini E; Talassi E; Tarchini R; Gaetti L; Bellomi A
    G Ital Nefrol; 2003; 20(4):419-22. PubMed ID: 14523904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verner-Morrison syndrome. Literature review.
    Belei OA; Heredea ER; Boeriu E; Marcovici TM; Cerbu S; Mărginean O; Iacob ER; Iacob D; Motoc AGM; Boia ES
    Rom J Morphol Embryol; 2017; 58(2):371-376. PubMed ID: 28730220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome.
    Maheshwari RR; Desai M; Rao VP; Palanki RR; Namburi RP; Reddy KT; Reddy AP
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S215-8. PubMed ID: 24251163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of pancreatic cholera: a case report.
    Kirkpatrick AW; Hanna SS; Skinner BA
    Can J Surg; 1996 Apr; 39(2):155-8. PubMed ID: 8769928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma.
    Negro A; Verzicco I; Tedeschi S; Campanini N; Zanelli M; Negri E; Farnetti E; Nicoli D; Palladini B; Santi R; Cunzi D; Calvi A; Coghi P; Gerra L; Volpi R; Graiani G; Cabassi A
    Front Endocrinol (Lausanne); 2021; 12():652045. PubMed ID: 33815297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
    Song S; Shi R; Li B; Liu Y
    Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All you need to know about VIPoma: Review on the latest studies.
    Karele EN
    Presse Med; 2024 Jun; 53(2):104222. PubMed ID: 38109967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pancreatic VIPoma. Report of one case].
    Urdangarin A; Iñiguez G; Benavides C; Castillo C; Castro A; Castillos I; Corredoira Y; Soto N
    Rev Med Chil; 2010 Jul; 138(7):841-6. PubMed ID: 21043079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide reverses shock due to vasoactive intestinal peptide-secreting adrenal pheochromocytoma: A case report and review of literature.
    Hu X; Cao W; Zhao M
    World J Clin Cases; 2018 Nov; 6(14):862-868. PubMed ID: 30510956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.